Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BIAF exchanges : Nasdaq save search
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -7.22%
H: 0.0%
C: -3.33%
lung initiative cancer for
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 2.97%
H: 1.92%
C: 0.48%
year financial results
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board
Published: 2024-02-06 (Crawled : 13:30) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -0.38%
H: 0.64%
C: -0.64%
lung network medical
bioAffinity Technologies In The News - January 30, 2024
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 2.5%
H: 0.51%
C: -2.44%
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer - January 23, 2024
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 5.3%
H: 0.0%
C: -2.52%
award patent cancer treatment
bioAffinity Technologies In the News
Published: 2024-01-08 (Crawled : 14:30) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 7.22%
H: 0.0%
C: -4.88%
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Published: 2023-11-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 0.6%
H: 0.0%
C: -2.39%
lung cancer
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -2.33%
H: 7.14%
C: 2.93%
business update financial results
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 5.49%
H: 0.0%
C: -8.05%
sales
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 8.33%
H: 0.0%
C: -5.59%
conference growth
Funds' Portfolios Must Reflect Their Name, SEC Says | PLANADVISER – PLANADVISER
Published: 2023-09-20 (Crawled : 23:00) - spacfeed.com
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
AMERGIN ASSET MANAGEMENT ANNOUNCES ACQUISITION OF … – PR Newswire
Published: 2023-09-20 (Crawled : 23:00) - spacfeed.com
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
management acquisition
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF … – PR Newswire
Published: 2023-09-20 (Crawled : 22:00) - spacfeed.com
BGC | $7.565 -0.33% -0.33% 3M
|
n/a
|
| O: -2.07%
H: 3.37%
C: 1.73%
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
ICCT | $1.27 2.42% 2.36% 93K
|
Professional, Scientific, and T...
|
| O: -6.11%
H: 21.95%
C: 10.03%
network
PRIME AE Enhances Midwest Presence with Jacobi, Toombs … – PR Newswire
Published: 2023-09-20 (Crawled : 22:00) - spacfeed.com
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
ICCT | $1.27 2.42% 2.36% 93K
|
Professional, Scientific, and T...
|
| O: -6.11%
H: 21.95%
C: 10.03%
prime
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
Published: 2023-09-19 (Crawled : 14:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -0.05%
H: 1.18%
C: -3.58%
services
bioAffinity Technologies Presents Research Findings at CYTO 2023
Published: 2023-05-22 (Crawled : 14:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 0.0%
H: 3.83%
C: 3.83%
research
bioAffinity Technologies Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -5.37%
H: 5.67%
C: 3.96%
financial results
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
Published: 2023-05-01 (Crawled : 13:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: -0.51%
H: 7.22%
C: 5.67%
financial
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 2.44%
H: 0.0%
C: -2.38%
lung symposium cancer
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
Published: 2023-03-28 (Crawled : 13:00) - biospace.com/
BIAF | $2.82 2.17% 2.13% 130K
|
|
| O: 1.76%
H: 2.03%
C: -6.03%
cypath lung cancer publication
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.